News
4h
News-Medical.Net on MSNPathpresenter receives FDA 510(K) clearance for digital pathology clinical viewerPathPresenter, a leading Image Management System and workflow platform for digital pathology, has received U.S. Food and Drug ...
However, Bluesound has upgraded the new Powermode so that its a superior home theater hub and allows you to build out a ...
The firm's Clinical Viewer is cleared for use with the Hamamatsu NanoZoomer S360MD Slide scanner, NDPI image formats, and the Barco NV MDPC-8127 display.
Micro E-Mini Nasdaq 100 Futures Crack Rising Wedge—Loss of 21,820 Support Signals Drop Toward 21,370
Hawkish Fed outlook and mixed tech earnings compound technical breakdown, as bulls must defend January–February 2025 lows at 21,370 or risk a deeper pullback into the 20,000 region. Three-Month Rising ...
It is diagnosed by histopathology interpretation of Hematoxylin and Eosin (H&E)-stained tissue sections. Gland and nuclei distributions vary with the disease grade, and the morphological features vary ...
Cancer researchers have a multitude of tools to study tumors. Histological staining uses dyes to make different kinds of ...
This beach will certainly be a brand new tourist attraction for Detroit Lakes," said Alderman Ron Zeman. "We’ll have something a lot of cities wish they had.” ...
Zilliz, the company behind the open-source vector database Milvus, today announced the release of Milvus 2.6, furthering the company's long-standing mission to democratize AI through accessible and ...
Silicon Valley has a grand vision of AI replacing doctors. But this story isn’t about that. Instead, it’s a story about overlooked places like Parbhani, where technology helps exhausted pathologists ...
Explore the booming Artificial Intelligence in Pathology market. Asia-Pacific leads the market, while North America is the fastest-growing region. Major players include Roche, Philips, and Paige.ai.
A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists ...
Analysts Applaud UiPath's AI Traction, But Net New ARR Slide Sparks Caution. ... Price Action: PATH shares are trading higher by 1.20% to $13.10 at last check Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results